Home / Inspections / 1243797

FDA Inspection 1243797 — Hikma Pharmaceuticals USA INC.

Hikma Pharmaceuticals USA INC. — FEI 1510690

The FDA completed an inspection of Hikma Pharmaceuticals USA INC. on July 23, 2024 in Columbus, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 23, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Compliance: Devices
Location
Columbus, OH (United States)

Facility

Other inspections at this facility

  • 1303412 (NAI Thu Apr 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1238509 (NAI Fri Jan 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1182363 (NAI Thu Sep 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1113855 (NAI Fri Nov 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1090395 (NAI Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources